Progress in the management of acute colchicine poisoning in adults

J Wu, Z Liu - Internal and emergency medicine, 2022 - Springer
Colchicine is a tricyclic, lipid-soluble alkaloid which has long been used to treat gout and
many immunological diseases. Due to its narrow therapeutic window and long half-life of …

Current concepts of the pathogenesis of aplastic anemia

C Liu, Y Sun, Z Shao - Current pharmaceutical design, 2019 - ingentaconnect.com
Abnormal activation of the immune system plays an important role in the pathogenesis of
aplastic anemia (AA). Various immune cells and cytokines constitute a complex immune …

Recombinant human thrombopoietin increases platelet count in severe thrombocytopenic patients with hepatitis B‐related cirrhosis: Multicentre real‐world …

R Feng, Y Liu, XL Zhu, WY Zhai, Y He… - Journal of viral …, 2022 - Wiley Online Library
Patients with hepatitis B‐related cirrhosis complicated with thrombocytopenia have a higher
risk of bleeding, which may lead to higher mortality. We aimed to explore the efficacy and …

A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation

YQ Sun, Y Kong, XH Zhang, Y Wang, MM Shi, Y Song… - Platelets, 2019 - Taylor & Francis
Patients with prolonged isolated thrombocytopenia (PT) after allogeneic stem cell
transplantation (allo-SCT) are known to have a poor prognosis. However, there is no …

Aplastic anemia in China

C Liu, Z Shao - Journal of Translational Internal Medicine, 2018 - degruyter.com
Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now,
severe aplastic anemia (SAA) has been recognized by international and domestic scholars …

[HTML][HTML] Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation

M Tian, L Ma, J Chen, Q Gong - Current Research in Translational …, 2025 - Elsevier
Delayed platelet engraftment (DPE) and thrombocytopenia are common complications
following myeloablative conditioning in the advanced stage of allogeneic haematopoietic …

Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia

X Wang, H Bi, L Liu, Y Liu, L Yin, J Yao, J Yu, W Tao… - Platelets, 2023 - Taylor & Francis
The conventional dose of recombinant human thrombopoietin (rhTPO) in the treatment of
immune thrombocytopenia (ITP) is 300 U/kg per day, but the clinical reaction rate is not …

[HTML][HTML] Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells

G Berlian, OM Tandrasasmita… - Asian Pacific Journal of …, 2017 - Elsevier
Objective To study the regulation of trombinol on thrombopoietin, an essential regulator of
thrombocyte production. Methods Effect of trombinol on thrombopoietin regulation was …

[HTML][HTML] 重组人血小板生成素对非重型再生障碍性贫血免疫抑制治疗疗效的影响

张梦露, 陈婉淑, 韩冰 - Chinese Journal of Hematology, 2020 - ncbi.nlm.nih.gov
重组人血小板生成素对非重型再生障碍性贫血免疫抑制治疗疗效的影响- PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

[HTML][HTML] 阿伐曲泊帕转换治疗TPO 受体激动剂难治性再生障碍性贫血疗效及安全性

井丽萍, 樊慧慧, 杨文睿, 李园, 李建平… - Chinese Journal of …, 2022 - ncbi.nlm.nih.gov
阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性- PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …